Revumenib Shows Promise for Advanced Acute Myeloid Leukemia
WEBApr 18, 2023 · A new type of targeted therapy shows promise for acute myeloid leukemia (AML), one of the most difficult leukemias to treat. The drug, revumenib, is part of a group, or class, of drugs known as menin inhibitors.
FDA Approves New Targeted Treatment for Acute Myeloid Leukemia
WEBRye Brook, N.Y., July 25, 2023 – The U.S. Food and Drug Administration (FDA) last week approved quizartinib (Vanflyta®) in combination with standard chemotherapies for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that carries a genetic mutation called FLT3-ITD.
Acute myeloid leukaemia - Latest research and news | Nature
WEB5 days ago · Acute myeloid leukemia is a type of cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The cancer develops from myeloid blasts cells that would...
New combinations and targeted therapies for acute myeloid leukemia …
WEBDec 11, 2023 · Acute myeloid leukemia is a cancer characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood-cell production. It's one of...
New CAR T Cell Clinical Trial for Acute Myeloid Leukemia Is First …
WEBApr 22, 2024 · Acute myeloid leukemia (AML) is one of the most challenging blood cancers. The disease moves quickly and needs aggressive treatment with chemotherapy, sometimes followed by a bone marrow transplant. Even when the first round of therapy works, AML often returns. Now a clinical trial at Memorial Sloan Kettering Cancer Center (MSK) offers hope for ...
FDA approves first treatment for certain types of poor-prognosis acute …
WEBThe U.S. Food and Drug Administration today approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with...
Outcomes After Stem Cell Transplant in Elderly Patients With Acute ...
WEBMar 22, 2024 · Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021, leukemia-free and overall survival improved significantly over time, according to results from a study published in Clinical Cancer Research, a journal of the American ...
FDA approves Mylotarg for treatment of acute myeloid leukemia
WEBThe U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33...
FDA approves olutasidenib for relapsed or refractory acute myeloid ...
WEBOn December 1, 2022, the Food and Drug Administration (FDA) approved olutasidenib (Rezlidhia) capsules for adult patients with relapsed or refractory acute myeloid leukemia (AML) with a ...
Blood test identifies acute myeloid leukemia patients at greater …
WEBMar 7, 2023 · Using special a screening technology, researchers at the National Institutes of Health have identified two common mutations in blood cells that make some adults in remission from acute myeloid leukemia (AML) more likely to relapse or die within three years after having a bone marrow transplant than those without the mutations.